Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm

Neurosurgery
Matthew J McGirtRichard E Clatterbuck

Abstract

Experimental evidence suggests that intercellular adhesion molecule-1 mediated leukocyte extravasation contributes to the pathogenesis of cerebral vasospasm. Simvastatin, an HMG-CoA reductase inhibitor, decreases intercellular adhesion molecule-1 expression and competitively inhibits leukocyte intercellular adhesion molecule-1 binding. We hypothesized that administration of simvastatin after the onset of subarachnoid hemorrhage (SAH) would attenuate perivascular granulocyte migration and ameliorate cerebral vasospasm in a rabbit model of SAH. New Zealand white rabbits (n = 15) underwent injection of autologous blood into the cisterna magna or sham surgery followed by subcutaneous injection of simvastatin (40 mg/kg) or vehicle 30 minutes, 24 hours, and 48 hours after SAH or sham surgery. Seventy-two hours later, basilar artery lumen diameter was measured by in situ perfusion/fixation and image analysis. CD-18 monoclonal antibody stained perivascular granulocytes and macrophages were counted under light microscopy. In vehicle treated rabbits, mean +/- standard deviation basilar artery diameter was reduced 3 days after SAH (n = 5) versus sham (n = 5) rabbits (0.49 +/- 0.08 mm versus 0.75 +/- 0.03 mm, P < 0.01). After SAH, mean +/-...Continue Reading

References

May 1, 1990·Journal of Neurosurgery·J W PetersonN T Zervas
Jul 1, 1985·Stroke; a Journal of Cerebral Circulation·N F KassellG Nazar
Apr 1, 1996·Journal of Neurosurgery·R M PlutaE H Oldfield
Oct 28, 1997·Stroke; a Journal of Cerebral Circulation·E M OshiroR J Tamargo
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M EndresJ K Liao
Nov 13, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·S BellostaF Bernini
Jul 25, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·M RomanoA Mantovani
Dec 2, 2000·Nature Medicine·B KwakF Mach
Mar 20, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·K FassbenderM Hennerici
Apr 13, 2002·Japanese Journal of Pharmacology·Richard SercombePhilippe Gomis
Dec 7, 2002·Stroke; a Journal of Cerebral Circulation·Matthew J McGirtDavid S Warner
Apr 17, 2003·Drugs of Today·Milita Crisby
Jun 26, 2003·Neurosurgery·Aaron S DumontKevin S Lee
May 1, 2004·Stroke; a Journal of Cerebral Circulation·Toshiyuki SasakiIturo Inoue

❮ Previous
Next ❯

Citations

Apr 30, 2010·Neurosurgical Review·Jorge Humberto Tapia-PérezThomas Schneider
Jun 9, 2009·Current Atherosclerosis Reports·Larry B Goldstein
Jan 18, 2012·Current Treatment Options in Neurology·Rajat Dhar, Michael Diringer
Aug 27, 2009·Neurocritical Care·Alejandro A Rabinstein
Sep 25, 2009·Neurocritical Care·Tomoko R SampsonMichael N Diringer
Dec 17, 2010·Molecular Neurobiology·Fatima A SehbaJohn H Zhang
Feb 5, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Elissa F Wible, Daniel T Laskowitz
Jul 21, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R EichelR R Leker
Mar 21, 2009·Neurological Research·Ryszard M PlutaJohn H Zhang
Dec 19, 2013·Current Treatment Options in Neurology·Saef Izzy, Susanne Muehlschlegel
Jul 24, 2013·Neurology Research International·Michael SiutaJ Mocco
Jan 10, 2009·Neurological Research·Eric Michael DeshaiesA John Popp
Dec 26, 2008·Neurological Research·Eric Michael DeshaiesA John Popp
Aug 12, 2014·BioMed Research International·Brandon A MillerGustavo Pradilla
Jul 28, 2013·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Iveta PoljakovaJana Zapletalova
Sep 19, 2007·Expert Opinion on Emerging Drugs·Paul A Lapchak, Dalia M Araujo
Oct 12, 2010·World Neurosurgery·Mohammed Sabri, R Loch Macdonald
Jul 16, 2010·Medicina intensiva·M Ruiz-BailénR J Obra-Cuadra
Feb 24, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Michael KernChristopher R P Lind
Apr 27, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Tommaso ZoerleR Loch Macdonald
Oct 16, 2007·Annales Françaises D'anesthèsie Et De Rèanimation·B TavernierB Riegel
Sep 18, 2007·Journal of Neuroscience Methods·Takashi SugawaraJohn H Zhang
Aug 24, 2010·British Journal of Neurosurgery·Serge MarbacherNeil D Kitchen
Nov 9, 2014·Translational Stroke Research·Yuichiro KikkawaTomio Sasaki
Apr 22, 2011·Journal of Pharmacy Practice·Denise H RhoneyXi Liu-DeRyke
Jun 3, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Mohammed SabriRobert Loch Macdonald
Jul 29, 2008·Stroke; a Journal of Cerebral Circulation·Victoria A H SillbergJeffrey J Perry
Jun 13, 2009·Stroke; a Journal of Cerebral Circulation·Roelof RisseladaMiriam C J M Sturkenboom

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.